Filing Details
- Accession Number:
- 0000950170-25-081939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-04 20:41:08
- Reporting Period:
- 2025-06-02
- Filing Date:
- 2025-06-04
- Accepted Time:
- 2025-06-04 20:41:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286199 | K Joseph Belanoff | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-02 | 4,881 | $78.42 | 2,937,104 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Common Stock | Disposition | 2025-06-02 | 3,050 | $79.48 | 2,934,054 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Common Stock | Disposition | 2025-06-02 | 2,988 | $80.30 | 2,931,066 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Common Stock | Disposition | 2025-06-02 | 1,820 | $81.33 | 2,929,246 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Common Stock | Disposition | 2025-06-02 | 1,263 | $82.26 | 2,927,983 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Common Stock | Disposition | 2025-06-02 | 4,631 | $83.46 | 2,923,352 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Common Stock | Disposition | 2025-06-02 | 12,959 | $84.57 | 2,910,393 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Common Stock | Disposition | 2025-06-02 | 8,408 | $85.01 | 2,901,985 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
Footnotes
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $77.84 to $78.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $78.88 to $79.865 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.90 to $80.8925 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.92 to $81.78 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $81.935 to $82.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $82.96 to $83.95 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.975 to $84.94 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.00 to $85.31 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Billionaire Hedge Funds
